How do clinicians use post-COVID syndrome diagnosis? Analysis of clinical features in a Swedish COVID-19 cohort with 18 months’ follow-up: a national observational cohort and matched cohort studyShow others and affiliations
2024 (English)In: BMJ Public Health, E-ISSN 2753-4294, Vol. 2, no 1, article id e000336Article in journal (Refereed) Published
Abstract [en]
Introduction: SARS-CoV-2 infection causes acute COVID-19 and may result in post-COVID syndrome (PCS). We aimed to investigate how clinicians diagnose PCS and identify associated clinical and demographic characteristics.
Methods: We analysed multiregistry data of all SARS-CoV-2 test-positive individuals in Sweden (n=1 057 174) between 1 February 2020 and 25 May 2021. We described clinical characteristics that prompt PCS diagnosis in outpatient and inpatient settings. In total, there were 6389 individuals with a hospital inpatient or outpatient diagnosis for PCS. To understand symptomatology, we examined individuals diagnosed with PCS at least 3 months after COVID-19 onset (n=6389) and assessed factors associated with PCS diagnosis.
Results: Mechanical ventilation correlated with PCS (OR 114.7, 95% CI 105.1 to 125.3) compared with no outpatient/inpatient contact during initial COVID-19. Dyspnoea (13.4%), malaise/fatigue (8%) and abnormal pulmonary diagnostic imaging findings (4.3%) were the most common features linked to PCS. We compared clinical features of PCS with matched controls (COVID-19 negative, n=23 795) and COVID-19 severity-matched patients (COVID-19 positive, n=25 556). Hypertension associated with PCS cohort (26.61%) than in COVID-19-negative (OR 17.16, 95% CI 15.23 to 19.3) and COVID-19-positive (OR 9.25, 95% CI 8.41 to 10.16) controls, although most individuals received this diagnosis before COVID-19. Dyspnoea was the second most common feature in the PCS cohort (17.2%), and new to the majority compared with COVID-19-negative (OR 54.16, 95% CI 42.86 to 68.45) and COVID-19-positive (OR 18.7, 95% CI 16.21 to 21.57) controls.
Conclusions: Our findings highlight factors Swedish physicians associate with PCS.
Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2024. Vol. 2, no 1, article id e000336
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:umu:diva-224009DOI: 10.1136/bmjph-2023-000336OAI: oai:DiVA.org:umu-224009DiVA, id: diva2:1856195
Funder
The Research Council of Norway, 262700Academy of Finland, 340539Swedish Research Council, 2021-06536Region Västerbotten, RV-967545Region Västerbotten, RV-9677832024-05-062024-05-062024-05-06Bibliographically approved